Proteapex Therapeutics
In The Media

June 16, 2019

CSO Discusses ECPF-1, a Novel Osteoarthritis Therapeutic

Dr. Marina D’Angelo, CSO, discussed development of ECPF-1, the novel, injectable therapeutic that slows the progression of osteoarthritis.

April 23, 2018

ProteaPex Therapeutics featured in a short film

ProteaPex Therapeutics is presenting several posters at the 2018 Experimental Biology meeting in San Diego, CA. In addition, we are featured in a short film as part of the Thought Leadership Series.

November 14, 2016

ECPF-2, is the subject of a proof-of-concept competition

Our periodontal disease therapeutic, ECPF-2, is the subject of a proof-of-concept competition grant proposal to the University City Science Center. The winners will be announced early 2017.

September 3, 2015

PCOM Faculty Spotlight - Marina D'Angelo PhD

Marina D'Angelo, PhD, CSO and co-founder of ProteaPex Therapeutics, was the recent subject of a Faculty Spotlight.

May 8, 2015

Proteapex Therapeutics featured on Inside Higher Education's Academic Minute

Our lead OA product, ECPF-1, was recently featured on public radio in a segment on pet osteoarthritis.